InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,549.90
(
0.74%
)
US TECH 100
19,784.80
(
0.73%
)
Dow Jones
39,293.98
(
-0.04%
)
Brent Oil
87.58
(
0.28%
)
Bitcoin
56,490.38
(
-0.87%
)
Post# of 252490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Titan V

Send PM Follow Ignore
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Titan V

Re: xavierprivas post# 213552

Monday, 09/11/2017 12:07:55 PM

Monday, September 11, 2017 12:07:55 PM

Post# of 252490
Thanks for your input xavierprivas. For the PPD trial, do you think them using Captisol-enabled Ganaxalone this time will not make much of a difference? Captisol seems to be used with 7 FDA approved drugs already.

Btw I'm very much intrigued by Ecor1 taking that big of a position in MRNS at this time, being early investors in SAGE. Doesn't seem like they have low confidence in MRNS. Currently MRNS market cap is only 3% that of SAGE.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up